Caricamento...
Use of Microdosing and Accelerator Mass Spectrometry To Evaluate the Pharmacokinetic Linearity of a Novel Tricyclic GyrB/ParE Inhibitor in Rats
Determining the pharmacokinetics (PKs) of drug candidates is essential for understanding their biological fate. The ability to obtain human PK information early in the drug development process can help determine if future development is warranted. Microdosing was developed to assess human PKs, at ul...
Salvato in:
Pubblicato in: | Antimicrob Agents Chemother |
---|---|
Autori principali: | , , , , |
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
American Society for Microbiology
2014
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4249412/ https://ncbi.nlm.nih.gov/pubmed/25136019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03300-14 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|